Stoevesandt D, Steglich J, Bartelt J, Kurch L, McCarten K, Flerlage J
Radiology. 2025; 314(1):e232650.
PMID: 39835977
PMC: 11783165.
DOI: 10.1148/radiol.232650.
Hesko C, Heath J, Roth M, Mittal N
Hematology Am Soc Hematol Educ Program. 2024; 2024(1):27-33.
PMID: 39643982
PMC: 11665597.
DOI: 10.1182/hematology.2024000526.
Kahn J, Mauz-Korholz C, Hernandez T, Milgrom S, Castellino S
Am Soc Clin Oncol Educ Book. 2024; 44(3):e432420.
PMID: 38788179
PMC: 11562960.
DOI: 10.1200/EDBK_432420.
Stoevesandt D, Ludwig C, Mauz-Korholz C, Korholz D, Hasenclever D, McCarten K
Pediatr Radiol. 2024; 54(5):725-736.
PMID: 38296856
PMC: 11056341.
DOI: 10.1007/s00247-024-05859-y.
Wyatt K, Birz S, Castellino S, Henderson T, Lucas Jr J, Pei Q
J Natl Cancer Inst. 2024; 116(5):642-646.
PMID: 38273668
PMC: 11077302.
DOI: 10.1093/jnci/djae013.
Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH.
Zijtregtop E, Zeal J, Metzger M, Kelly K, Mauz-Koerholz C, Voss S
Blood Adv. 2023; 7(20):6303-6319.
PMID: 37522740
PMC: 10589789.
DOI: 10.1182/bloodadvances.2023010024.
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
Castellino S, Giulino-Roth L, Harker-Murray P, Kahn J, Forlenza C, Cho S
Pediatr Blood Cancer. 2023; 70 Suppl 6:e30580.
PMID: 37505794
PMC: 10660893.
DOI: 10.1002/pbc.30580.
Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Mhlanga J, Alazraki A, Cho S, Lai H, Nadel H, Pandit-Taskar N
Pediatr Blood Cancer. 2022; 70 Suppl 4:e29968.
PMID: 36114654
PMC: 10641880.
DOI: 10.1002/pbc.29968.
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.
Milgrom S, Kim J, Chirindel A, Kim J, Pei Q, Chen L
Pediatr Blood Cancer. 2021; 68(9):e29212.
PMID: 34245210
PMC: 8809108.
DOI: 10.1002/pbc.29212.
[Lymphoma in children and adolescents].
Sorge I, Georgi T, Hirsch F
Radiologe. 2021; 61(7):611-618.
PMID: 34160645
DOI: 10.1007/s00117-021-00873-9.
Whole-body MRI versus an [F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.
Spijkers S, Littooij A, Kwee T, Tolboom N, Beishuizen A, Bruin M
Eur Radiol. 2021; 31(12):8925-8936.
PMID: 34021390
PMC: 8589741.
DOI: 10.1007/s00330-021-08026-1.
Fluorine-fluorodeoxyglucose PET/CT Imaging in Childhood Malignancies.
Bicakci N, Elli M
Mol Imaging Radionucl Ther. 2021; 30(1):18-27.
PMID: 33586403
PMC: 7885281.
DOI: 10.4274/mirt.galenos.2020.64436.
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric F-FDG PET/CT for Oncology 1.0.
Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M
J Nucl Med. 2020; 62(1):99-110.
PMID: 33334912
PMC: 8679588.
DOI: 10.2967/jnumed.120.254110.
Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
McCarten K, Nadel H, Shulkin B, Cho S
Pediatr Radiol. 2019; 49(11):1545-1564.
PMID: 31620854
DOI: 10.1007/s00247-019-04529-8.
Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.
Kahn J, Kelly K
Pediatr Blood Cancer. 2018; 65(7):e27033.
PMID: 29603618
PMC: 5980713.
DOI: 10.1002/pbc.27033.
Pharmacotherapeutic Management of Pediatric Lymphoma.
Mauz-Korholz C, Stroter N, Baumann J, Botzen A, Korholz K, Korholz D
Paediatr Drugs. 2017; 20(1):43-57.
PMID: 29127674
DOI: 10.1007/s40272-017-0265-x.
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting.
Colleran G, Kwatra N, Oberg L, Grant F, Drubach L, Callahan M
Cancer Imaging. 2017; 17(1):28.
PMID: 29116015
PMC: 5678769.
DOI: 10.1186/s40644-017-0130-8.
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson T, Parsons S, Wroblewski K, Chen L, Hong F, Smith S
Cancer. 2017; 124(1):136-144.
PMID: 28902390
PMC: 5735034.
DOI: 10.1002/cncr.30979.